Pharmaceutical Labeling Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Pharmaceutical 
Labeling Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  I MA R C  G r ou p ,  t i t l e d  " P h a r m a c eu t i ca l  L a b e l in g  
Ma r k e t :  G l o b a l  In d u s t r y  T r e n d s ,  S h a r e ,  S i ze ,  G r o w t h ,  O p p o r t u n i ty  a n d  F o r e c a s t  
20 2 4 - 2 03 2 , "  t h e  g l ob a l  p ha r ma c e u t i c a l  l a b e l i n g  m a r k e t  s i z e  r e ac h e d  U S $  6 . 0  B i l l i o n  i n  
20 2 3 .
Report Fac tors  A f fec t ing  the  Growth  o f  t he  Pharmaceut ica l  Labe l ing  Indus t ry :
St r ingent  Regula t ory  Requ i rements:
I n  re c e n t  y e a r s ,  t h e  p h a r ma c e u t i c a l  s e c t o r  h a s  e xp e r i e n c ed  a  n o t ab l e  r i s e  i n  re g u l a t o ry  
Highlight and de m a n ds  co n c e r n i ng  d ru g  l a b e l i n g .  A u t h o r i t i e s  su c h  a s  t h e  U . S .  F o o d  a n d  D r ug  
A dm i n i s t ra t i o n  ( F D A )  a n d  t h e  E u r o p ea n  Me d i c i n es  A ge n c y  ( E M A )  h a v e  e s ta b l i s h e d  
s t r i n g e n t  g u i de l i n e s  a i me d  a t  e n su r i n g  b o t h  p a t i e n t  s a fe t y  a n d  t h e  e f f ec t i v e n es s  o f  
Description p r o d u c ts .  T h es e  r e gu l a t i o n s  a d d r es s  v a r i o u s  e l e m en t s ,  i n c l u d i n g  t h e  p r o v i s i o n  o f  c l e a r  
an d  s u c c i n c t  d r u g  i n f o r m a t i o n ,  p re c i s e  d o s i n g  i n s t r uc t i o n s ,  a n d  a l e r t s  re g a r d i ng  
po s s i b l e  s i d e  e f fe c t s .  
A dh e r i n g  t o  t h e s e  r e g u l a t i o n s  i s  e s s en t i a l  f o r  p h a rm a c eu t i c a l  c o m pa n i e s  s e e k i n g  
ma r k e t  a p p r o v a l  f o r  t h e i r  o f f e r i n g s .  C o n s e qu e n t l y ,  t h e r e  ha s  b e e n  a n  i n c r e as i n g  n e e d  
f o r  s o p h i s t i c a t e d  l ab e l i n g  s o l u t i on s  t h a t  c a n  a i d  i n  c o mp l i a n c e  a n d  m i t i g a t e  t h e  r i s k  o f  
no n - c o mp l i a n c e ,  t h e r eb y  p ro p e l l i n g  t h e  g ro w t h  o f  t he  p h a rm a c eu t i c a l  l ab e l i n g  ma r k e t .
Ris ing Global  Pharmaceut ica l  Product ion:
The  wor ldw ide  pharmaceut i ca l  sec to r  i s  exper ienc ing  s ign i f i can t  g rowt h ,  p rope l led  
by  var ious  f ac to rs  inc lud ing  an  ag ing  demograph i c ,  a  r i se  in  ch ron ic  d isease 
cases ,  and  t he  in t roduc t ion  o f  g roundbreak ing  t he rap ies .  Th is  expans ion  has  led  
Report t o  an  inc reased p roduc t ion  and  d i s t r ibu t ion  o f  pha rmaceut i ca l  p roduc t s  on  a  g loba l  sca le .  
I n  r esponse,  pharmaceu t i ca l  f i rms  a re  pursu ing  e f fec t i ve  and  dependab le  l abe l ing  
Highlight and so lu t ions  t o  add ress  the  su rg ing  demand .  Cont emporary  l abe l ing  techno log ies ,  
such  as  au tomat ion  and  d ig i t a l  p r in t ing ,  a l l ow  pharmaceut i ca l  m anuf ac tu rers  to  
Description improve  produc t ion  e f f i c i ency ,  m in im ize  e r ro r s ,  and  guaran tee  prec ise  l abe l ing  o f  t he i r  p roduc t s ,  t hereby  f ac i l i t a t ing  t he  g rowt h  o f  t he  pharmaceu t i ca l  l abe l ing  
marke t .
Product  Traceabi l i ty  and Ster i l i za t ion  Requirements:
I n  r esponse  to  the  inc reas ing  preva lence o f  coun te r fe i t  med ica t ions  and  the  
demand  fo r  p roduc t  t r aceab i l i t y ,  num erous  coun t r ies  and  reg ions  have  enac ted  
se r i a l i za t i on  and t r ack -and- t race  regu la t ions  fo r  pha rmaceu t i ca l  p roduc ts .  
Ser ia l i za t ion  en t a i l s  t he  ass ignment  o f  a  d is t inc t  i den t i f i ca t i on  code to  each  
ind i v idua l  un i t  o f  a  d rug ,  f ac i l i t a t ing  i t s  t r ack ing  th roughou t  t he  supp l y  cha in .
Th is  p rocess  i s  c ruc ia l  fo r  ve r i f y ing  the  au then t i c i t y  o f  pha rmaceu t i ca ls  and  fo r  
thwar t ing  the  en t ry  o f  coun te r fe i t  d rugs  in to  the  marke tp lace .  The  
pharmaceu t ica l  labe l ing  indus t ry  has  addressed  th is  requ i rement  by  c rea t ing  
labe l ing  so lu t ions  tha t  in teg ra te  se r ia l i za t ion  and  t raceab i l i t y  capab i l i t ies .  
Such  so lu t ions  ass is t  pharmaceu t ica l  compan ies  in  adher ing  to  regu la to ry  
Report s tandards  wh i le  ma in ta in ing  the  in teg r i t y  o f  the i r  p roduc ts .
Highlight and Request  for  a  PDF sample  o f  th is  repor t :  h t tps : / /www. imarcgroup .com/pha rmaceu t ica l - labe l ing -marke t / reques tsamp le
Description
Report Description
Global  Pharmaceutical  Label ing Market Trends:
The b iopharmaceut ica l  secto r  i s  exper ienc ing  s ign i f i cant  growth ,  marked by a  surge  in  the in t roduct ion  o f  
b io log ics  and  b ios imi la rs  in to  the  marke tp lace.  These soph is t i ca ted  medica l  p roducts  necess i ta te  spec ia l ized  
labe l ing  that  prov ides  comprehens ive  deta i l s  regard ing the i r  compos i t ion ,  hand l ing,  and app l i ca t ion.  The  
demand for  innova t ive  labe l ing  technolog ies  i s  inc reas ing,  dr i ven  by  shor te r  p roduct ion  cyc les  and  the  need 
fo r  adaptab le  labe l ing  so lu t ions  tha t  meet  the  d is t inc t  requ i rements  o f  th is  indus t ry .  
Add i t iona l l y ,  the  movement  towards  persona l i zed  med ic ine ,  wh ich focuses on  cus tomiz ing t rea tments  based 
on  ind iv idua l  gene t ic  pro f i les ,  has  he ightened the  need fo r  ta i lo red  pharmaceut ica l  labe ls .  Each  pat ien t ’s  
medica t ion  may inc lude spec i f i c  dos ing gu ide l ines,  mak ing  i t  essen t ia l  fo r  labe ls  to  accura te ly  communicate  
th is  in format ion .  Advanced pr in t ing  and labe l ing  technolog ies  a re  fac i l i ta t ing  the  e f f ic ient  c reat ion  o f  
persona l ized  labe ls ,  thereby  prope l l ing  the g rowth  o f  the  pharmaceut ica l  labe l ing sec to r .
View Report  TOC,  F igures and Tables :  h t tps: / /www. imarcgroup.com/pharmaceut ica l - labe l ing-market
Breakup by Label Type:
• Pressure-Sensit ive Label
• Glue-Appl ied Label
• Sleeve Label
• In-Mold Label
• Others
Report 
Breakup by Material:
Segmentation
• Paper
• Polymer Fi lm
• Others
Breakup by Application:
• Instruct ional  Label
• Decorat ive Label
• Functional  Label
• Promotional  Label
• Others
Report Breakup by End Use:
• Bottles
Segmentation • Bl ister Packs
• Parenteral  Containers
• Pre-Fi l lable Syringes
• Pre-Fi l lable Inhalers
• Pouches
• Others
Breakup by Region:
• North America
• Europe
• Asia Pacifi c
• Latin America
Report • Middle East and Afr ica
Segmentation
• 3M
• Avery Denn ison  Corporat ion
• Bemis
• CCL Indus t r ies
• Essentra
• L INTEC
• SATO Ho ld ings
Competitive • Advanced Labe ls
• Edwards  Labe l
Landscape 
• J e t  Labe l
with Key • Conso l idated  Labe l
• Axon
Players • Clabro  Labe l
• Class ic  Labe l
• Maver ick  Labe l
• Metro  Labe l
• Progress ive  Labe l
• MCC Labe l
• Merc ian  Labe ls
• Taylor  Labe l
How big is the global pharmaceutical labeling market?
What is the expected growth rate of the global 
pharmaceutical labeling market during 2024-2032?
What are the key factors driving the global 
pharmaceutical labeling market?
Key 
What has been the impact of COVID-19 on the global 
pharmaceutical labeling market?
Questions 
What is the breakup of the global pharmaceutical 
Answered in labeling market based on the label type?
the Report What is the breakup of the global pharmaceutical labeling market based on the material?
What is the breakup of the global pharmaceutical 
labeling market based on the end use?
What are the key regions in the global pharmaceutical 
labeling market?
Who are the key players/companies in the global 
pharmaceutical labeling market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5    G l o b a l  P h a r m a c e u t i c a l  L a b e l i n g  M a r k e t    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  B r e a k u p  b y  L a b e l  T y p e
    5 . 5     M a r k e t  B r e a k u p  b y  M a t e r i a l
    5 . 6     M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    5 . 7     M a r k e t  B r e a k u p  b y  E n d  U s e
    5 . 8     M a r k e t  B r e a k u p  b y  R e g i o n
    5 . 9     M a r k e t  F o r e c a s t
6    M a r k e t  B r e a k u p  b y  L a b e l  T y p e
    6 . 1     P r e s s u r e - S e n s i t i v e  L a b e l
        6 . 1 . 1     M a r k e t  T r e n d s
        6 . 1 . 2     M a r k e t  F o r e c a s t
    6 . 2     G l u e - A p p l i e d  L a b e l
        6 . 2 . 1     M a r k e t  T r e n d s
        6 . 2 . 2     M a r k e t  F o r e c a s t
       
    6 . 3     S l e e v e  L a b e l
        6 . 3 . 1     M a r k e t  T r e n d s
        6 . 3 . 2     M a r k e t  F o r e c a s t
    6 . 4     I n - M o l d  L a b e l
        6 . 4 . 1     M a r k e t  T r e n d s
        6 . 4 . 2     M a r k e t  F o r e c a s t
    6 . 5     O t h e r s  
        6 . 5 . 1     M a r k e t  T r e n d s
        6 . 5 . 2     M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  M a t e r i a l  
    7 . 1     P a p e r
Table of         7 . 1 . 1     M a r k e t  T r e n d s        7 . 1 . 2     M a r k e t  F o r e c a s t
    7 . 2     P o l y m e r  F i l m
        7 . 2 . 1     M a r k e t  T r e n d s
Contents         7 . 2 . 2     M a r k e t  F o r e c a s t    7 . 3     O t h e r s
        7 . 3 . 1     M a r k e t  T r e n d s
        7 . 3 . 2     M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n  
    8 . 1     I n s t r u c t i o n a l  L a b e l  
        8 . 1 . 1     M a r k e t  T r e n d s
        8 . 1 . 2     M a r k e t  F o r e c a s t
    8 . 2     D e c o r a t i v e  L a b e l  
        8 . 2 . 1     M a r k e t  T r e n d s
        8 . 2 . 2     M a r k e t  F o r e c a s t
    8 . 3     F u n c t i o n a l  L a b e l  
        8 . 3 . 1     M a r k e t  T r e n d s
        8 . 3 . 2     M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /p ha rm a c eut i c a l - l a be l i n g -m a rke t /
t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: